Bioatla Historical Balance Sheet

BCAB Stock

USD 0.35 0.01 2.78%

Trend analysis of Bioatla balance sheet accounts such as Short Long Term Debt Total of 2.1 M, Other Current Liabilities of 15.1 M or Total Current Liabilities of 25.6 M provides information on Bioatla's total assets, liabilities, and equity, which is the actual value of Bioatla to its prevalent stockholders. By breaking down trends over time using Bioatla balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Bioatla latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Bioatla is a good buy for the upcoming year.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bioatla. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

For information on how to trade Bioatla Stock refer to our How to Trade Bioatla Stock guide.

About Bioatla Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Bioatla at a specified time, usually calculated after every quarter, six months, or one year. Bioatla Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Bioatla and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Bioatla currently owns. An asset can also be divided into two categories, current and non-current.

Bioatla Balance Sheet Chart

At present, Bioatla's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Total Stockholder Equity is expected to grow to about 107.7 M, whereas Short and Long Term Debt Total is forecasted to decline to about 2.1 M.

Total Assets Short Long Term Debt Total Other Current Liab Total Current Liabilities Non Current Liabilities Total

Add Fundamental

Total Assets

Total assets refers to the total amount of Bioatla assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Bioatla books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Bioatla balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Bioatla are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Most accounts from Bioatla's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Bioatla current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bioatla. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

For information on how to trade Bioatla Stock refer to our How to Trade Bioatla Stock guide.At present, Bioatla's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Total Stockholder Equity is expected to grow to about 107.7 M, whereas Short and Long Term Debt Total is forecasted to decline to about 2.1 M.

	2022	2023	2024	2025 (projected)
Short and Long Term Debt Total	4.0M	2.5M	2.2M	2.1M
Total Assets	225.7M	119.7M	137.6M	159.6M

Short Long Term Debt Total Total Assets

Bioatla balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Property Plant And Equipment Gross
Total Assets		-0.9	0.61	0.72	1.0	-0.61	0.94	0.59	0.91	-0.99	-0.49	0.23	1.0	0.61	0.78	-0.21	-0.9	1.0	-0.93	0.66	-0.88	0.71	0.85	-0.43	1.0	0.76
Short Long Term Debt Total	-0.9		-0.79	-0.81	-0.89	0.67	-0.99	-0.26	-0.98	0.87	0.73	-0.36	-0.9	-0.29	-0.82	0.51	0.93	-0.9	0.98	-0.82	0.94	-0.89	-0.93	0.5	-0.92	-0.76
Other Current Liab	0.61	-0.79		0.8	0.58	-0.15	0.81	0.12	0.84	-0.57	-0.92	0.62	0.61	0.15	0.85	-0.64	-0.83	0.61	-0.82	0.97	-0.61	0.89	0.93	-0.01	0.66	0.89
Total Current Liabilities	0.72	-0.81	0.8		0.69	-0.4	0.82	0.19	0.85	-0.7	-0.67	0.74	0.72	0.22	0.96	-0.32	-0.92	0.72	-0.84	0.91	-0.81	0.77	0.82	0.01	0.74	0.65
Total Stockholder Equity	1.0	-0.89	0.58	0.69		-0.65	0.92	0.58	0.89	-0.99	-0.45	0.17	1.0	0.6	0.74	-0.19	-0.88	1.0	-0.92	0.62	-0.88	0.69	0.83	-0.48	0.99	0.73
Other Liab	-0.61	0.67	-0.15	-0.4	-0.65		-0.59	0.01	-0.53	0.61	0.06	0.16	-0.62	0.0	-0.29	0.04	0.44	-0.62	0.55	-0.22	0.83	-0.35	-0.4	0.83	-0.63	-0.08
Net Tangible Assets	0.94	-0.99	0.81	0.82	0.92	-0.59		0.4	0.99	-0.9	-0.73	0.37	0.93	0.43	0.86	-0.46	-0.96	0.93	-1.0	0.83	-0.91	0.89	0.95	-0.43	0.95	0.84
Property Plant And Equipment Net	0.59	-0.26	0.12	0.19	0.58	0.01	0.4		0.39	-0.57	-0.05	-0.07	0.59	1.0	0.39	0.23	-0.43	0.59	-0.39	0.13	-0.19	0.19	0.29	-0.04	0.53	0.51
Current Deferred Revenue	0.91	-0.98	0.84	0.85	0.89	-0.53	0.99	0.39		-0.87	-0.78	0.46	0.9	0.41	0.9	-0.5	-0.97	0.9	-0.99	0.88	-0.89	0.93	0.95	-0.36	0.92	0.85
Net Debt	-0.99	0.87	-0.57	-0.7	-0.99	0.61	-0.9	-0.57	-0.87		0.43	-0.19	-0.99	-0.59	-0.74	0.15	0.87	-0.99	0.9	-0.62	0.87	-0.65	-0.82	0.41	-0.99	-0.73
Retained Earnings	-0.49	0.73	-0.92	-0.67	-0.45	0.06	-0.73	-0.05	-0.78	0.43		-0.65	-0.48	-0.07	-0.74	0.85	0.75	-0.48	0.75	-0.88	0.5	-0.93	-0.83	0.03	-0.53	-0.82
Accounts Payable	0.23	-0.36	0.62	0.74	0.17	0.16	0.37	-0.07	0.46	-0.19	-0.65		0.22	-0.04	0.71	-0.49	-0.56	0.22	-0.42	0.73	-0.29	0.6	0.5	0.48	0.24	0.45
Cash	1.0	-0.9	0.61	0.72	1.0	-0.62	0.93	0.59	0.9	-0.99	-0.48	0.22		0.61	0.78	-0.2	-0.9	1.0	-0.93	0.65	-0.88	0.71	0.84	-0.44	1.0	0.75
Non Current Assets Total	0.61	-0.29	0.15	0.22	0.6	0.0	0.43	1.0	0.41	-0.59	-0.07	-0.04	0.61		0.42	0.22	-0.46	0.61	-0.42	0.16	-0.22	0.22	0.31	-0.04	0.55	0.53
Non Currrent Assets Other	0.78	-0.82	0.85	0.96	0.74	-0.29	0.86	0.39	0.9	-0.74	-0.74	0.71	0.78	0.42		-0.36	-0.96	0.78	-0.88	0.93	-0.76	0.83	0.87	0.03	0.79	0.8
Other Assets	-0.21	0.51	-0.64	-0.32	-0.19	0.04	-0.46	0.23	-0.5	0.15	0.85	-0.49	-0.2	0.22	-0.36		0.4	-0.2	0.47	-0.59	0.27	-0.78	-0.58	0.19	-0.25	-0.55
Long Term Debt	-0.9	0.93	-0.83	-0.92	-0.88	0.44	-0.96	-0.43	-0.97	0.87	0.75	-0.56	-0.9	-0.46	-0.96	0.4		-0.9	0.97	-0.9	0.86	-0.88	-0.94	0.18	-0.91	-0.84
Cash And Short Term Investments	1.0	-0.9	0.61	0.72	1.0	-0.62	0.93	0.59	0.9	-0.99	-0.48	0.22	1.0	0.61	0.78	-0.2	-0.9		-0.93	0.65	-0.88	0.71	0.84	-0.44	1.0	0.75
Common Stock Total Equity	-0.93	0.98	-0.82	-0.84	-0.92	0.55	-1.0	-0.39	-0.99	0.9	0.75	-0.42	-0.93	-0.42	-0.88	0.47	0.97	-0.93		-0.86	0.9	-0.9	-0.96	0.37	-0.95	-0.85
Common Stock Shares Outstanding	0.66	-0.82	0.97	0.91	0.62	-0.22	0.83	0.13	0.88	-0.62	-0.88	0.73	0.65	0.16	0.93	-0.59	-0.9	0.65	-0.86		-0.7	0.9	0.92	0.02	0.7	0.84
Non Current Liabilities Total	-0.88	0.94	-0.61	-0.81	-0.88	0.83	-0.91	-0.19	-0.89	0.87	0.5	-0.29	-0.88	-0.22	-0.76	0.27	0.86	-0.88	0.9	-0.7		-0.72	-0.8	0.54	-0.9	-0.55
Other Current Assets	0.71	-0.89	0.89	0.77	0.69	-0.35	0.89	0.19	0.93	-0.65	-0.93	0.6	0.71	0.22	0.83	-0.78	-0.88	0.71	-0.9	0.9	-0.72		0.92	-0.27	0.74	0.85
Other Stockholder Equity	0.85	-0.93	0.93	0.82	0.83	-0.4	0.95	0.29	0.95	-0.82	-0.83	0.5	0.84	0.31	0.87	-0.58	-0.94	0.84	-0.96	0.92	-0.8	0.92		-0.25	0.88	0.92
Total Liab	-0.43	0.5	-0.01	0.01	-0.48	0.83	-0.43	-0.04	-0.36	0.41	0.03	0.48	-0.44	-0.04	0.03	0.19	0.18	-0.44	0.37	0.02	0.54	-0.27	-0.25		-0.44	-0.07
Net Invested Capital	1.0	-0.92	0.66	0.74	0.99	-0.63	0.95	0.53	0.92	-0.99	-0.53	0.24	1.0	0.55	0.79	-0.25	-0.91	1.0	-0.95	0.7	-0.9	0.74	0.88	-0.44		0.78
Property Plant And Equipment Gross	0.76	-0.76	0.89	0.65	0.73	-0.08	0.84	0.51	0.85	-0.73	-0.82	0.45	0.75	0.53	0.8	-0.55	-0.84	0.75	-0.85	0.84	-0.55	0.85	0.92	-0.07	0.78

Click cells to compare fundamentals

Bioatla Account Relationship Matchups

Bioatla balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	244.9M	254.4M	225.7M	119.7M	137.6M	159.6M
Short Long Term Debt Total	682K	5.4M	4.0M	2.5M	2.2M	2.1M
Other Current Liab	10.0M	15.9M	15.9M	22.9M	26.3M	15.1M
Total Current Liabilities	32.3M	19.8M	23.1M	28.3M	32.6M	25.6M
Total Stockholder Equity	210.0M	210.8M	180.3M	70.7M	81.3M	107.7M
Net Tangible Assets	(145.3M)	210.0M	210.8M	180.3M	207.4M	217.8M
Property Plant And Equipment Net	4.1M	7.0M	5.2M	3.1M	3.6M	5.1M
Net Debt	(237.9M)	(239.6M)	(211.5M)	(109.0M)	(98.1M)	(103.0M)
Retained Earnings	(90.9M)	(186.3M)	(292.8M)	(416.3M)	(374.6M)	(355.9M)
Accounts Payable	2.5M	1.2M	4.2M	3.8M	4.4M	3.4M
Cash	238.6M	245.0M	215.5M	111.5M	128.2M	151.3M
Non Current Assets Total	4.3M	7.1M	5.3M	3.3M	3.7M	5.3M
Cash And Short Term Investments	238.6M	245.0M	215.5M	111.5M	128.2M	151.3M
Liabilities And Stockholders Equity	244.9M	254.4M	225.7M	119.7M	137.6M	159.6M
Non Current Liabilities Total	2.7M	23.8M	22.3M	20.6M	18.6M	19.2M
Other Current Assets	2.1M	2.3M	4.9M	4.9M	5.7M	6.0M
Other Stockholder Equity	300.9M	397.1M	473.1M	486.9M	560.0M	304.7M
Total Liab	35.0M	43.6M	45.4M	49.0M	44.1M	37.8M
Net Invested Capital	210.7M	210.8M	180.3M	70.7M	81.3M	81.1M
Property Plant And Equipment Gross	4.1M	11.2M	10.5M	9.2M	10.6M	8.0M
Total Current Assets	240.7M	247.3M	220.4M	116.4M	133.9M	154.4M
Net Working Capital	208.4M	227.5M	197.3M	88.1M	101.3M	128.8M
Property Plant Equipment	4.7M	4.1M	7.0M	2.7M	3.1M	4.9M
Short Term Debt	682K	2.8M	3.0M	1.6M	1.5M	2.9M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
S	SentinelOne
GM	General Motors

When determining whether Bioatla offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bioatla's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bioatla Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bioatla Stock:

How To Invest In Bioatla

Details

Is Bioatla Stock a good investment?

Details

What is Bioatla's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

For information on how to trade Bioatla Stock refer to our How to Trade Bioatla Stock guide.

You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bioatla. If investors know Bioatla will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bioatla listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(1.70)

Revenue Per Share

0.228

Quarterly Revenue Growth

0.316

Return On Assets

(0.50)

Return On Equity

(1.39)

The market value of Bioatla is measured differently than its book value, which is the value of Bioatla that is recorded on the company's balance sheet. Investors also form their own opinion of Bioatla's value that differs from its market value or its book value, called intrinsic value, which is Bioatla's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bioatla's market value can be influenced by many factors that don't directly affect Bioatla's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Bioatla's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bioatla is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bioatla's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Bioatla Historical Balance Sheet

About Bioatla Balance Sheet Analysis

Bioatla Balance Sheet Chart

Total Assets

Total Current Liabilities

Bioatla balance sheet Correlations

Bioatla Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Bioatla balance sheet Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Cash	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Total Assets
Net Invested Capital	+ 1.0	Total Assets
Cash	+ 1.0	Total Stockholder Equity
Cash And Short Term Investments	+ 1.0	Total Stockholder Equity

Common Stock Total Equity	- 1.0	Net Tangible Assets
Net Invested Capital	- 0.99	Net Debt
Cash And Short Term Investments	- 0.99	Net Debt
Cash	- 0.99	Net Debt
Common Stock Total Equity	- 0.99	Current Deferred Revenue
Net Debt	- 0.99	Total Stockholder Equity